• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Bowles P, Brenek SJ, Caron S, Do NM, Drexler MT, Duan S, Dubé P, Hansen EC, Jones BP, Jones KN, Ljubicic TA, Makowski TW, Mustakis J, Nelson JD, Olivier M, Peng Z, Perfect HH, Place DW, Ragan JA, Salisbury JJ, Stanchina CL, Vanderplas BC, Webster ME, Weekly RM. Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin. Org Process Res Dev 2014. [DOI: 10.1021/op4002802] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
2
Peng Z, Ragan JA, Colon-Cruz R, Conway BG, Cordi EM, Leeman K, Letendre LJ, Ping LJ, Sieser JE, Singer RA, Sluggett GW, Strohmeyer H, Vanderplas BC, Blunt J, Mawby N, Meldrum K, Taylor S. Synthesis of Filibuvir. Part II. Second-Generation Synthesis of a 6,6-Disubstituted 2H-Pyranone via Dieckmann Cyclization of a β-Acetoxy Ester. Org Process Res Dev 2013. [DOI: 10.1021/op400236r] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
3
Withbroe GJ, Seadeek C, Girard KP, Guinness SM, Vanderplas BC, Vaidyanathan R. A Robust, Streamlined Approach to Bosutinib Monohydrate. Org Process Res Dev 2012. [DOI: 10.1021/op300087r] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
4
Ragan JA, Ide ND, Cai W, Cawley JJ, Colon-Cruz R, Kumar R, Peng Z, Vanderplas BC. Development of a Practical and Efficient Synthesis of Chloromethyl 2-Ethoxy-2-methylpropanoate. Org Process Res Dev 2010. [DOI: 10.1021/op1002038] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
5
Brandt TA, Caron S, Damon DB, DiBrino J, Ghosh A, Griffith DA, Kedia S, Ragan JA, Rose PR, Vanderplas BC, Wei L. Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity. Tetrahedron 2009. [DOI: 10.1016/j.tet.2008.10.067] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
6
Chouai A, Venditto VJ, Simanek EE, Vanderplas BC, Ragan JA. LARGE SCALE, GREEN SYNTHESIS OF A GENERATION-1 MELAMINE (TRIAZINE) DENDRIMER. Organic Synth 2009;86:151. [PMID: 20072717 PMCID: PMC2805095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
7
Ragan JA, Bourassa DE, Blunt J, Breen D, Busch FR, Cordi EM, Damon DB, Do N, Engtrakul A, Lynch D, McDermott RE, Mongillo JA, O’Sullivan MM, Rose PR, Vanderplas BC. Development of a Practical and Efficient Synthesis of CP-945,598-01, a CB1 Antagonist for the Treatment of Obesity. Org Process Res Dev 2008. [DOI: 10.1021/op800255j] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
8
Ruggeri SG, Vanderplas BC, Anderson BG, Breitenbach R, Urban FJ, Stewart, III AM, Young GR. Regioselective Addition of Mesitol to a 2,4-Dichloropyridine. Org Process Res Dev 2008. [DOI: 10.1021/op800004q] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
9
Andresen BM, Caron S, Couturier M, DeVries KM, Do NM, Dupont-Gaudet K, Ghosh A, Girardin M, Hawkins JM, Makowski TM, Riou M, Sieser JE, Tucker JL, Vanderplas BC, Watson TJ. Process Research and Scale-up of the κ-Opioid Receptor Agonist CJ-15,161 Drug Candidate. Chimia (Aarau) 2006. [DOI: 10.2533/chimia.2006.554] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]  Open
10
Vanderplas BC, DeVries KM, Fox DE, Raggon JW, Snyder MW, Urban FJ. Process Research and Scale-Up for a β-3 Adrenergic Receptor Agonist. Org Process Res Dev 2004. [DOI: 10.1021/op049969o] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
11
Ragan JA, am Ende DJ, Brenek SJ, Eisenbeis SA, Singer RA, Tickner DL, Teixeira JJ, Vanderplas BC, Weston N. Safe Execution of a Large-Scale Ozonolysis:  Preparation of the Bisulfite Adduct of 2-Hydroxyindan-2-carboxaldehyde and Its Utility in a Reductive Amination. Org Process Res Dev 2003. [DOI: 10.1021/op0202235] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
12
Dupont J, Bemish R, McCarthy KE, Payne ER, Pollard EB, Ripin DH, Vanderplas BC, Watrous RM. Corrigendum to “Oxidation of carbamate-protected alkylhydrazines to the corresponding hydrazones under Swern conditions”. Tetrahedron Lett 2001. [DOI: 10.1016/s0040-4039(01)01009-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA